NASDAQ : CLGN
CollPlant Biotechnologies Ltd. — Financial statements
Healthcare · Biotechnology · Israel
Last price 4.135 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 7.82M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
CollPlant Biotechnologies Ltd. (CLGN) reported revenue of 318.00K USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 318.00K | 2.37M | 515.00K | 10.96M | 299.00K | 15.64M |
| Cost of Revenue | 1.34M | 835.00K | 1.62M | 1.99M | 400.00K | 2.00M |
| Gross Profit | -1.02M | 1.54M | -1.11M | 8.97M | -101.00K | 13.64M |
| Selling, General & Admin | 4.47M | 4.83M | 5.63M | 6.00M | 6.74M | 5.94M |
| Research & Development | 6.91M | 8.19M | 10.52M | 10.48M | 10.26M | 7.63M |
| Operating Expenses | 11.38M | 13.02M | 16.14M | 16.48M | 17.00M | 13.57M |
| Operating Income | -12.40M | -11.48M | -17.25M | -7.51M | -17.10M | 65.00K |
| Interest Expense | -75.00K | -24.00K | -7.00K | |||
| Interest & Investment Income | 353.00K | 380.00K | 738.00K | 788.00K | 321.00K | 219.00K |
| Currency Exchange Gain (Loss) | -371.00K | -371.00K | -79.00K | -285.00K | -115.00K | -38.00K |
| Other Non Operating Income (Expenses) | -15.00K | -15.00K | -17.00K | -10.00K | -10.00K | -2.00K |
| Pretax Income | -12.51M | -11.49M | -16.61M | -7.02M | -16.93M | 237.00K |
| Net Income | -12.51M | -11.49M | -16.61M | -7.02M | -16.93M | 237.00K |
| Net Income to Common | -12.51M | -11.49M | -16.61M | -7.02M | -16.93M | 237.00K |
| Shares Outstanding (Basic) | 1.34M | 1.22M | 1.15M | 1.14M | 1.10M | 996.90K |
| Shares Outstanding (Diluted) | 1.34M | 1.22M | 1.15M | 1.14M | 1.10M | 1.20M |
| EPS (Basic) | -9.32 | -9.41 | -14.50 | -6.16 | -15.34 | 0.24 |
| EPS (Diluted) | -9.32 | -9.41 | -14.50 | -6.16 | -15.34 | 0.20 |
| Free Cash Flow | -11.29M | -9.45M | -14.58M | -3.72M | -14.97M | 1.07M |
| Free Cash Flow Per Share | -8.41 | -7.74 | -12.72 | -3.26 | -13.57 | 0.90 |
| Gross Margin | 64.78% | -215.53% | 81.83% | -33.78% | 87.18% | |
| Operating Margin | -3,900.94% | -484.31% | -3,349.71% | -68.55% | -5,718.06% | 0.42% |
| Profit Margin | -3,934.91% | -484.56% | -3,225.05% | -64.05% | -5,660.53% | 1.52% |
| Free Cash Flow Margin | -3,548.74% | -398.44% | -2,830.29% | -33.92% | -5,007.36% | 6.86% |
| EBITDA | -11.56M | -10.57M | -16.21M | -6.41M | -16.02M | 838.00K |
| EBITDA Margin | -58.49% | 5.36% | ||||
| D&A For EBITDA | 846.00K | 912.00K | 1.04M | 1.10M | 1.08M | 773.00K |
| EBIT | -12.40M | -11.48M | -17.25M | -7.51M | -17.10M | 65.00K |
| EBIT Margin | -68.55% | 0.42% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 2.56M | 5.59M | 11.91M | 26.67M | 29.65M | 13.15M |
| Short-Term Investments | 30.15M | |||||
| Cash & Short-Term Investments | 2.56M | 5.59M | 11.91M | 26.67M | 29.65M | 43.30M |
| Accounts Receivable | 16.00K | 1.00K | 150.00K | 9.00K | 270.00K | |
| Other Receivables | 389.00K | 223.00K | 433.00K | 393.00K | 543.00K | 424.00K |
| Receivables | 405.00K | 224.00K | 583.00K | 393.00K | 552.00K | 694.00K |
| Inventory | 540.00K | 573.00K | 440.00K | 714.00K | 1.43M | 1.08M |
| Other Current Assets | 392.00K | 359.00K | 248.00K | 241.00K | 23.00K | 13.00K |
| Total Current Assets | 3.90M | 6.75M | 13.18M | 28.02M | 31.66M | 45.09M |
| Property, Plant & Equipment | 3.17M | 3.89M | 5.28M | 5.86M | 5.68M | 5.68M |
| Other Intangible Assets | 45.00K | 73.00K | 131.00K | 188.00K | 245.00K | 243.00K |
| Other Long-Term Assets | 83.00K | 76.00K | 118.00K | 57.00K | 188.00K | 213.00K |
| Total Assets | 7.20M | 10.79M | 18.71M | 34.13M | 37.77M | 51.22M |
| Accounts Payable | 256.00K | 610.00K | 870.00K | 980.00K | 1.13M | 1.03M |
| Accrued Expenses | 1.34M | 1.25M | 1.29M | 1.65M | 1.44M | 1.43M |
| Current Portion of Leases | 894.00K | 814.00K | 806.00K | 624.00K | 529.00K | 519.00K |
| Current Unearned Revenue | 32.00K | |||||
| Total Current Liabilities | 2.49M | 2.67M | 2.97M | 3.25M | 3.10M | 3.01M |
| Long-Term Leases | 1.77M | 2.03M | 2.27M | 2.54M | 2.38M | 3.09M |
| Total Liabilities | 4.25M | 4.70M | 5.25M | 5.79M | 5.49M | 6.10M |
| Common Stock | 6.26M | 5.49M | 4.98M | 4.98M | 4.87M | 4.66M |
| Additional Paid-In Capital | 128.31M | 126.40M | 122.80M | 121.07M | 118.10M | 114.22M |
| Retained Earnings | -130.66M | -124.84M | -113.35M | -96.74M | -89.72M | -72.80M |
| Comprehensive Income & Other | -969.00K | -969.00K | -969.00K | -969.00K | -969.00K | -969.00K |
| Shareholders' Equity | 2.94M | 6.08M | 13.46M | 28.34M | 32.28M | 45.12M |
| Total Liabilities & Equity | 7.20M | 10.79M | 18.71M | 34.13M | 37.77M | 51.22M |
| Total Debt | 2.66M | 2.85M | 3.08M | 3.16M | 2.91M | 3.61M |
| Net Cash (Debt) | -101.00K | 2.75M | 8.83M | 23.52M | 26.74M | 39.69M |
| Net Cash Per Share | -0.08 | 2.25 | 7.71 | 20.65 | 24.24 | 33.17 |
| Filing Date Shares Outstanding | 1.44M | 1.44M | 1.15M | 1.15M | 1.08M | 1.08M |
| Total Common Shares Outstanding | 1.44M | 1.28M | 1.15M | 1.15M | 1.08M | 1.08M |
| Working Capital | 1.41M | 4.08M | 10.21M | 24.77M | 28.55M | 42.07M |
| Book Value Per Share | 2.04 | 4.75 | 11.76 | 24.75 | 29.97 | 41.89 |
| Tangible Book Value | 2.90M | 6.01M | 13.33M | 28.15M | 32.04M | 44.88M |
| Tangible Book Value Per Share | 2.01 | 4.69 | 11.64 | 24.58 | 29.74 | 41.66 |
| Machinery | 5.68M | 5.66M | 5.33M | 4.70M | 4.11M | |
| Leasehold Improvements | 3.66M | 3.65M | 3.50M | 3.31M | 2.63M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -12.51M | -11.49M | -16.61M | -7.02M | -16.93M | 237.00K |
| Depreciation & Amortization | 846.00K | 912.00K | 1.04M | 1.10M | 1.08M | 773.00K |
| Loss (Gain) From Sale of Assets | 30.00K | 18.00K | ||||
| Stock-Based Compensation | 609.00K | 999.00K | 1.72M | 1.94M | 2.17M | 1.60M |
| Other Operating Activities | -60.00K | -95.00K | 131.00K | 351.00K | 521.00K | -322.00K |
| Change in Accounts Receivable | -16.00K | 149.00K | -150.00K | 9.00K | 261.00K | 560.00K |
| Change in Inventory | 18.00K | -129.00K | 280.00K | 749.00K | -312.00K | 181.00K |
| Change in Accounts Payable | -315.00K | -260.00K | -110.00K | -153.00K | 99.00K | 236.00K |
| Change in Unearned Revenue | -32.00K | -175.00K | ||||
| Change in Other Net Operating Assets | 207.00K | 494.00K | -392.00K | 243.00K | -560.00K | -586.00K |
| Operating Cash Flow | -11.19M | -9.42M | -14.09M | -2.76M | -13.70M | 2.50M |
| Capital Expenditures | -91.00K | -28.00K | -483.00K | -954.00K | -1.27M | -1.43M |
| Sale of Property, Plant & Equipment | 83.00K | 1.00K | 1.00K | 68.00K | 33.00K | |
| Sale (Purchase) of Intangibles | -42.00K | -161.00K | ||||
| Investment in Securities | 30.24M | -30.00M | ||||
| Other Investing Activities | -57.00K | -270.00K | ||||
| Investing Cash Flow | -8.00K | -27.00K | -539.00K | -1.16M | 28.92M | -31.56M |
| Issuance of Common Stock | 1.72M | 3.10M | 9.00K | 1.11M | 1.87M | 38.76M |
| Other Financing Activities | 620.00K | |||||
| Financing Cash Flow | 2.34M | 3.10M | 9.00K | 1.11M | 1.87M | 38.76M |
| Foreign Exchange Rate Adjustments | -12.00K | 26.00K | -142.00K | -379.00K | -608.00K | 143.00K |
| Net Cash Flow | -8.88M | -6.32M | -14.77M | -3.19M | 16.49M | 9.85M |
| Free Cash Flow | -11.29M | -9.45M | -14.58M | -3.72M | -14.97M | 1.07M |
| Free Cash Flow Margin | -3,548.74% | -398.44% | -2,830.29% | -33.92% | -5,007.36% | 6.86% |
| Free Cash Flow Per Share | -8.41 | -7.74 | -12.72 | -3.26 | -13.57 | 0.90 |
| Levered Free Cash Flow | -6.89M | -5.48M | -8.89M | -1.90M | -8.90M | 942.25K |
| Unlevered Free Cash Flow | -6.85M | -5.48M | -8.89M | -1.90M | -8.89M | 946.62K |
| Cash Income Tax Paid | 16.00K | 16.00K | 62.00K | 8.00K | 31.00K | |
| Change in Working Capital | -106.00K | 254.00K | -372.00K | 848.00K | -544.00K | 216.00K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 7.82M | 17.89M | 41.24M | 73.18M | 93.25M | 174.91M |
| Enterprise Value | 7.92M | 12.28M | 29.12M | 47.30M | 63.35M | 132.39M |
| Last Close Price | 4.13 | 14.00 | 36.00 | 63.90 | 83.50 | 163.60 |
| PE Ratio | 738.04 | |||||
| Forward PE | 11.49 | 12.02 | 12.02 | 12.02 | 17.40 | |
| PS Ratio | 24.59 | 7.54 | 80.07 | 6.68 | 311.88 | 11.18 |
| PB Ratio | 2.03 | 2.94 | 3.06 | 2.58 | 2.89 | 3.88 |
| P/TBV Ratio | 2.70 | 2.98 | 3.09 | 2.60 | 2.91 | 3.90 |
| P/FCF Ratio | 163.01 | |||||
| P/OCF Ratio | 69.94 | |||||
| EV/Sales Ratio | 24.90 | 5.18 | 56.54 | 4.32 | 211.86 | 8.46 |
| EV/EBITDA Ratio | 157.99 | |||||
| EV/EBIT Ratio | 2,036.83 | |||||
| EV/FCF Ratio | 123.39 | |||||
| Debt / Equity Ratio | 0.90 | 0.47 | 0.23 | 0.11 | 0.09 | 0.08 |
| Debt / EBITDA Ratio | 2.43 | |||||
| Debt / FCF Ratio | 3.36 | |||||
| Net Debt / Equity Ratio | 0.03 | -0.45 | -0.66 | -0.83 | -0.83 | -0.88 |
| Net Debt / EBITDA Ratio | -0.01 | 0.26 | 0.55 | 3.67 | 1.67 | -47.36 |
| Net Debt / FCF Ratio | -0.01 | 0.29 | 0.61 | 6.33 | 1.79 | -36.99 |
| Asset Turnover | 0.03 | 0.16 | 0.02 | 0.30 | 0.01 | 0.50 |
| Inventory Turnover | 2.45 | 1.65 | 2.82 | 1.86 | 0.32 | 1.71 |
| Quick Ratio | 1.19 | 2.18 | 4.21 | 8.33 | 9.73 | 14.60 |
| Current Ratio | 1.57 | 2.52 | 4.44 | 8.62 | 10.20 | 14.96 |
| Return on Equity (ROE) | -161.98% | -117.56% | -79.46% | -23.16% | -43.73% | 0.96% |
| Return on Assets (ROA) | -62.95% | -48.67% | -40.81% | -13.06% | -24.02% | 0.13% |
| Return on Capital Employed (ROCE) | -263.30% | -141.50% | -109.60% | -24.30% | -49.30% | 0.10% |
| Earnings Yield | -225.42% | -64.23% | -40.28% | -9.59% | -18.15% | 0.14% |
| FCF Yield | -144.34% | -52.81% | -35.35% | -5.08% | -16.05% | 0.61% |
| Buyback Yield / Dilution | -16.22% | -6.54% | -0.57% | -3.23% | 7.80% | -73.76% |